It has also been reported that almost 7% of COVID-19 vaccinated individuals (both adenovirus vector-based vaccines and mRNA vaccines) have low titers of PF4 antibodies, but these antibodies are not functionally active (24). This evidence concerns the gene PF4 and COVID-19.